근적외선 이미징 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 적응증별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Near Infrared Imaging Market Size, Share & Trends Analysis Report By Product (Devices, Reagents), By Indication (Preclinical Imaging, Cancer Surgeries), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,404,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,816,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,641,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

근적외선 이미징 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 근적외선 이미징 시장 규모는 2025-2030년 동안 3.9%의 CAGR을 기록하여 2030년에는 28억 2,000만 달러에 달할 것으로 예상됩니다.

근적외선(NIR) 형광 이미징은 최소침습성, 다양한 질환의 진단에 있어 높은 효율성 등의 장점으로 인해 사용이 확대되고 있으며, 예측 기간 동안 산업의 성장을 크게 촉진할 것으로 예상됩니다. 또한, 만성질환, 특히 노인 인구의 증가는 산업의 성장을 촉진하고 있습니다. 알츠하이머병, 치매, 관절염, 만성 신장 질환, 암, 심혈관질환(CVDs), 당뇨병은 더 나은 진단과 효과적인 치료를 위한 의사결정을 위해 NIR 이미징을 필요로 하는 널리 퍼진 질병 중 일부입니다.

예를 들어, 국제암연구소에 따르면 2020년 전 세계적으로 약 1,929만 2,789명의 암 환자가 새로 발생했습니다. 이 수치는 2025년에는 5,055만 0,287명에 달할 것으로 예상하고 있습니다. National Research University's Higher School of Economics에 따르면, 신경질환은 오늘날 장애와 사망의 주요 원인 중 하나이며, NIR 기술의 개발 확대는 전체 산업 발전에 중요한 역할을 할 것으로 예상됩니다. 장애 조정 생존 기간의 주요 원인 그룹으로 보고되고 있으며, 전 세계 사망자 수의 16.8%를 차지합니다.

주요 기업들의 기술적으로 진보된 형광 이미징 시스템 도입, 인수, 제휴, 정부 승인과 같은 전략적 이니셔티브는 산업 성장에 큰 영향을 미칠 것으로 예상됩니다. 예를 들어, 2021년 1월 올림푸스(Olympus Corp.)는 Quest Photonic Devices B.V.를 5,000만 유로에 인수하는 계약을 체결하여 수술용 내시경 기능을 향상시켰으며, NIR은 특히 제약 산업에서 공정 모니터링 도구로 선호되고 있습니다. 바이오 제약 기업 및 학술 기관의 상업 및 연구 활동에서 NIR의 연구 용도 확대는 향후 몇 년 동안 첨단 NIR 시스템에 대한 수요를 견인할 것으로 예상됩니다.

근적외선 이미징 시장 보고서 하이라이트

• 시약 제품 유형은 다양한 유형의 암을 식별하기 위한 새로운 시약의 개발로 인해 2024년 산업을 지배했습니다.
• 시약 부문은 뇌종양 및 혈관 수술 중 실시간 혈관조영 영상 등 인도시아닌그린(ICG)이 제공하는 이점으로 인해 예측 기간 동안 가장 빠른 CAGR을 기록하며 선두를 유지할 것으로 예상됩니다.
• 암 수술 분야는 특히 신흥국의 높은 유병률로 인해 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 병원 클리닉 최종 용도 부문은 2024년 클리닉과 병원의 암 환자 입원 건수 증가로 인해 이 산업을 지배했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 근적외선 이미징 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 근적외선 이미징 시장 : 제품 비즈니스 분석

• 제품 시장 점유율, 2024년과 2030년
• 제품 부문 대시보드
• 시장 규모와 예측과 동향 분석, 제품별, 2018-2030년
• 장비
• 시약

제5장 근적외선 이미징 시장 : 적응증 비즈니스 분석

• 적응증 시장 점유율, 2024년과 2030년
• 적응증 부문 대시보드
• 시장 규모와 예측과 동향 분석, 적응증별, 2018-2030년
• 전임상 이미징
• 암 수술
• 소화기외과 수술
• 심혈관 수술
• 성형외과/재건 수술
• 기타

제6장 근적외선 이미징 시장 : 최종 용도 비즈니스 분석

• 최종 용도 시장 점유율, 2024년과 2030년
• 최종 용도 부문 대시보드
• 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
• 병원 클리닉
• 제약·바이오테크놀러지 기업
• 실험실

제7장 근적외선 이미징 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 국가별, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 참여자 개요
• 기업의 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 개요/상장 기업
  • Quest Diagnostics Incorporated
  • Stryker
  • KARL STORZ SE & Co. KG
  • Olympus
  • Hamamatsu Photonics KK
  • Mizuho Medical Co., Ltd.
  • Shimadzu Corporation
  • Leica Microsystems
  • Medtronic(Visionsense)
  • PerkinElmer
  • Zeiss Group
  • FLUOPTICS SAS

ksm

영문 목차

영문목차

Near Infrared Imaging Market Growth & Trends:

The global near infrared imaging market size is expected to reach USD 2.82 billion by 2030, registering a CAGR of 3.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing usage of near infrared (NIR) fluorescence imaging due to the advantages, such as minimally invasiveness and high efficiency in diagnosing various conditions, is anticipated to drive the industry growth significantly during the forecast period. Moreover, growing incidences of chronic disorders, especially among the geriatric population, are fueling industry growth. Alzheimer's disease, dementia, arthritis, chronic kidney disease, cancer, Cardiovascular Diseases (CVDs), and diabetes are some of the commonly prevalent diseases that require NIR imaging for better diagnosis and further decision-making for effective treatment.

For instance, according to the International Agency for Research on Cancer in 2020, there were about 19,292,789 new cancer cases globally. The same source states that the number is expected to reach 50,550,287 by 2025. Expanding applications of the NIR technique in the early diagnosis of various neurological conditions are expected to play a significant role in the overall industry development. As per the National Research University's Higher School of Economics, neurological disorders are one of the leading causes of disability and death today. They were reported as the leading cause group of Disability Adjusted Life Years, which comprised 16.8% of global deaths.

Strategic initiatives, such as the introduction of technologically advanced fluorescence imaging systems, acquisitions, collaborations, and government approvals, by major companies, are expected to have a significant impact on the industry growth. For instance, in January 2021, Olympus Corp. entered into an agreement to acquire Quest Photonic Devices B.V. for EUR 50 million, to improve its surgical endoscopy capabilities. NIR is preferred as a process monitoring tool, especially in the pharmaceutical industry. Growing applications of NIR in commercial operations & research activities in biopharmaceutical companies as well as academic institutes are expected to drive the demand for advanced NIR systems in the coming years.

Near Infrared Imaging Market Report Highlights:

• The reagents product segment dominated the industry in 2024 owing to the development of novel reagents to identify various types of cancer
• The reagents segment is projected to expand further at the fastest CAGR retaining its leading position over the forecast years due to benefits offered by Indocyanine Green (ICG), such as real-time angiographic images during brain tumor or vascular surgery
• The cancer surgeries application segment is expected to grow at the fastest CAGR during the forecast period owing to the high prevalence of the disorder, especially in the emerging economies
• The hospitals & clinics end-use segment dominated the industry in 2024 owing to a rise in the number of admissions of cancer patients in clinics and hospitals

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Indication
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Near Infrared Imaging Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Near Infrared Imaging Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Devices
  • 4.4.1. Devices Market, 2018 - 2030 (USD Million)
  • 4.4.2. Near-infrared Fluorescence Imaging Systems
    • 4.4.2.1. Near-infrared Fluorescence Imaging Systems Market, 2018 - 2030 (USD Million)
  • 4.4.3. Near-infrared Fluorescence & Bioluminescence Imaging Systems
    • 4.4.3.1. Near-infrared Fluorescence & Bioluminescence Imaging Systems Market, 2018 - 2030 (USD Million)
• 4.5. Reagents
  • 4.5.1. Reagents Market, 2018 - 2030 (USD Million)
  • 4.5.2. Indocyanine Green (ICG)
    • 4.5.2.1. Indocyanine Green (ICG) Market, 2018 - 2030 (USD Million)
  • 4.5.3. Other Reagents
    • 4.5.3.1. Other Reagents Market, 2018 - 2030 (USD Million)

Chapter 5. Near Infrared Imaging Market: Indication Business Analysis

• 5.1. Indication Market Share, 2024 & 2030
• 5.2. Indication Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 5.4. Preclinical Imaging
  • 5.4.1. Preclinical Imaging Market, 2018 - 2030 (USD Million)
• 5.5. Cancer Surgeries
  • 5.5.1. Cancer Surgeries Market, 2018 - 2030 (USD Million)
• 5.6. Gastrointestinal Surgeries
  • 5.6.1. Gastrointestinal Surgeries Market, 2018 - 2030 (USD Million)
• 5.7. Cardiovascular Surgeries
  • 5.7.1. Cardiovascular Surgeries Market, 2018 - 2030 (USD Million)
• 5.8. Plastic/Reconstructive Surgeries
  • 5.8.1. Plastic/Reconstructive Surgeries Market, 2018 - 2030 (USD Million)
• 5.9. Other Applications
  • 5.9.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 6. Near Infrared Imaging Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals & Clinics
  • 6.4.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
• 6.5. Pharmaceutical & Biotechnology Companies
  • 6.5.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 6.6. Research Laboratories
  • 6.6.1. Research Laboratories Market, 2018 - 2030 (USD Million)

Chapter 7. Near Infrared Imaging Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Near Infrared Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Near Infrared Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Near Infrared Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Near Infrared Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Near Infrared Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Near Infrared Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Quest Diagnostics Incorporated
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Stryker
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. KARL STORZ SE & Co. KG
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Olympus
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Hamamatsu Photonics K.K.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Mizuho Medical Co., Ltd.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Shimadzu Corporation
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Leica Microsystems
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Medtronic (Visionsense)
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. PerkinElmer
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives
  • 8.5.11. Zeiss Group
    • 8.5.11.1. Overview
    • 8.5.11.2. Financial Performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic Initiatives
  • 8.5.12. FLUOPTICS SAS
    • 8.5.12.1. Overview
    • 8.5.12.2. Financial Performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic Initiatives

관련자료